Mean Platelet Volume in Hyperthyroid Toxic Adenoma Patients after Radioactive 131I Treatment | Zendy

Eda Şimşek | Zendy; Özge Timur | Zendy; Ayşe Çarlıoğlu | Zendy; Şenay Arıkan Durmaz | Zendy; Münir Demirci | Zendy; Hakan Sevimli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mean Platelet Volume in Hyperthyroid Toxic Adenoma Patients after Radioactive 131I Treatment

Author(s) -

Eda Şimşek,

Özge Timur,

Ayşe Çarlıoğlu,

Şenay Arıkan Durmaz,

Münir Demirci,

Hakan Sevimli

Publication year - 2015

Publication title -

advances in endocrinology

Language(s) - English

Resource type - Journals

eISSN - 2356-668X

pISSN - 2314-7903

DOI - 10.1155/2015/436768

Subject(s) - mean platelet volume , medicine , platelet , radioiodine therapy , ablation , adenoma , cardiology , endocrinology , gastroenterology , nuclear medicine , cancer , thyroid cancer

This study demonstrates that mean platelet volume (MPV) levels decrease after radioiodine (RAI) ablation therapy in hyperthyroid patients. Regarding the fact that large platelets are hemostatically more active, we suggest that hyperthyroid patients are at risk of cardiovascular disease despite all other cardiovascular risk factors. After RAI ablation therapy as MPV levels return to normal, cardiovascular risk for hyperthyroid patients reduces

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research